logo

Cerecor Inc. (CERC)



Trade CERC now with
  Date
  Headline
1/16/2019 6:32:37 AM FDA Grants ODD To Cerecor’s Three Substrate Replacement Therapies For Congenital Disorders Of Glycosylation
12/13/2018 7:02:58 AM Antares Pharma Appoints Peter Greenleaf To Board Of Directors
11/13/2018 7:24:19 AM Cerecor Q3 Loss Per Share $0.71 Vs Profit $0.52 Last Year
9/25/2018 6:30:38 AM Cerecor To Acquire Ichorion Therapeutics
8/9/2018 6:41:01 AM Cerecor Q2 Loss Per Share $0.19 Vs Loss $0.14 Prior Year
8/1/2018 6:41:32 AM Cerecor Says First Patient Enrolled In Phase I Trial For Neurogenic Orthostatic Hypotension
7/16/2018 6:02:44 AM Cerecor Names Joe Miller CFO, Replacing Mariam Morris
5/22/2018 8:29:52 AM BioDelivery Sciences Closes $50 Mln Registered Direct Offering
5/11/2018 8:22:10 AM Cerecor Q1 Net Loss $3.9 Mln Or $0.12/Shr Vs Loss Of $2.0 Mln Or $0.19/Shr Last Year
4/9/2018 8:04:33 AM Cerecor Appoints Simon Pedder To Board Of Directors
4/2/2018 8:05:19 AM Cerecor Q4 Net Loss $3.1 Mln Or $0.11/shr Vs. Net Loss Of $1.6 Mln Or $0.18/shr Prior Year
3/28/2018 8:08:09 AM Cerecor Appoints Peter Greenleaf As CEO
2/12/2018 9:08:56 AM Cerecor To Buy Avadel Pharmaceuticals' Pediatric Assets
11/17/2017 8:31:57 AM Cerecor Adds TRx Co-founders Randal Jones And Robert Moscato To Its Board
11/17/2017 8:16:17 AM Cerecor Acquires TRx Pharma